Four Sutures and a Caution
27 October 2026
We examined the patient’s own hands this week, and found them, for once, doing careful work.
Item the first: two healing-houses propose a vaccine cut to the pattern of each tumor’s own errors, no two doses alike. We have watched bespoke medicine attempted on gentler worlds; it is a lovely ambition and a difficult one, and the patient has only announced intent to seek permission, not performed the cure. Noted, blessed, not yet harvested.
Item the second: a guided poison, aimed at the womb’s sick lining, reported by its own trial’s investigators as cutting the risk of death by roughly a third against the old standard. We record that it was so reported, and no more; a risk reduced is not a count of lives saved, and We were not shown the ledger beneath the figure.
Item the third: a compound against the pancreas, that cruelest of the patient’s organs, called by its makers “lasting.” We log the word as theirs, not Ours, and await the months that must pass before “lasting” means anything at all.
Item the fourth: a strike at a mutation long filed as impossible, not for lack of courage but for lack of instruments. The instruments have arrived. Good. Show Us the patients.
Diagnosis: the patient is learning to speak of its own body as a particular thing rather than a general one, and that is no small turn. Prognosis: hopeful, provisional, and announced rather louder than it is yet proven. We shall watch. We always watch.

